TopLevel: No

Antibody buy for Piramal

24th December 2021

Submitted by:

Andrew Warmington

India-based CDMO Piramal Pharma has taken a 27.78% equity stake in Yapan Bio of Hyderabad

New R&D base for James Robinson

20th December 2021

Submitted by:

Andrew Warmington

James Robinson Speciality Ingredients (JRSI) has launched a dedicated 186 m2 biotechnology R&D facility in

Subscribe to Unsorted